-+ 0.00%
-+ 0.00%
-+ 0.00%

OCUGEN ANNOUNCES EARLY COMPLETION OF DOSING IN PHASE 2/3 PIVOTAL CONFIRMATORY TRIAL OF OCU410ST FOR STARGARDT DISEASE

Reuters·04/01/2026 11:02:00

Please log in to view news